|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61K 47/34 | |||
| A61K 47/02 |
| (11) | Patento numeris | 3432916 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17777119.3 |
| Europos patento paraiškos padavimo data | 2017-09-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/051394 |
| Data | 2017-09-13 |
| (87) | Numeris | WO 2018/053021 |
| Data | 2018-03-22 |
| (30) | Numeris | Data | Šalis |
| 201662394009 P | 2016-09-13 | US |
| (72) |
ABIAD, Maurice, US
DANI, Bhas, US
SHALAEV, Evgenyi, US
|
| (73) |
Allergan, Inc.,
2525 Dupont Drive, Irvine, California 92612,
US
|
| (54) | STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |
| STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS |